The percentage of patients with PGVs in MMR genes within this unselected glioblastoma cohort were compared to the percentage of patients with PGVs in MMR genes within other unselected cancer cohorts20,36–38 and the gnomAD v2.11 (non-cancer) cohort39. This evidence concerns the gene MRC1 and glioblastoma.